Cardiovascular and Interventional Radiological Society of Europe
EventsESIR CoursesDEB & cTACE in Primary and Secondary Liver Cancer 2018

DEB & cTACE in Primary and Secondary Liver Cancer, Villejuif/FR, December 13-14, 2018

HCC is a common type of cancer with increasing incidence. Intra-arterial therapies are often part of the treatment algorithm and several intra-arterial treatment options are available today, including C-TACE, DEB-TACE, balloon TACE and TARE. This Clinical Procedure Training course gives experienced physicians the opportunity to fine-tune their practical skills and learn more about current treatment options for various stages of HCC and liver metastatic disease.

Theoretical presentations will be organised to allow participants to understand the staging and treatment algorithm of HCC and metastatic liver disease. Hands-on sessions will then provide the opportunity to handle current devices and to learn about the most advanced technologies fit for intra-arterial therapy. Due to the complexity of treating HCC and liver metastases, collaboration between medical oncologists, surgeons and radiation therapists is needed. A section of the programme will be dedicated to imaging follow-up and treatment evaluation. Highly experienced physicians will present complications and lessons learned.

We hope you can join us at the prestigious Gustave Roussy Cancer Centre, located near Paris, for this exciting course!


Thursday, December 13, 2018




  • HCC overview of staging systems (BCLC, HKLC, others)
  • TACE in HCC: Patient selection to maximise outcomes and avoid complication
  • TACE HCC: Rationale to combine with systemic therapies, results, and possible future development
  • Is there any indication for TACE in advanced HCC patients?

Coffee break

TACE for Liver Metastases

  • TACE for NET: Patient selection, treatment outcomes and  systemic competitors
  • DEB-TACE for other metastases (colorectal, breast, …): Patient selection, technical points, treatment schedule and follow-up, systemic competitors

TACE Technique

  • Conventional TACE is better
  • Drug-eluting microsphere TACE is better


TACE in Clinical Practice

  • TACE for HCC in clinical practice: Treatment schedule, clinical and biological follow-up. When to stop? When to retreat?
  • How to evaluate response to TACE: RECIST, mRECIST, rRECIST, Choi?
  • TACE: Lesson learned from the worst complication I ever had
  • Discussion
  • TACE + Ablation: For whom, when, and how?

Coffee break

TACE in Clinical Practice

  • Balloon TACE: A new kid on the block
  • TACE or TARE: An honest appraisal, how to select patient and treatment?

The future of TACE

  • New drugs: Sunitinib? Vandetanib?
  • New drugs: Idarubicin?
  • Drugs are old-fashioned: Suicide genes

Friday, December 14, 2018

LC Live cases

  • Live case #1: C-TACE
  • Live case #2: DEB-TACE



  • Liver arterial anatomy relevant to intra-arterial therapies
  • Tips and tricks for C-TACE: Emulsions and embolic
  • Drug-eluting microspheres: Are they all the same? What are the differences? How do I use them?
  • Advanced microcatheter

Certificate of attendance

Local host

T. de Baère, Villejuif (FR)


I. Bargellini, Pisa (IT)
T. de Baère, Villejuif (FR)
A. Denys, Lausanne (CH)
F. Deschamps, Villejuif (FR)
B. Guiu, Montferrier sur Lez (FR)
T. Jakobs, Munich (DE)
O. Pellerin, Paris (FR)
M. Ronot, Clichy (FR)
L. Tselikas, Villejuif (FR)


Institut Gustave Roussy
39 Rue Camille Desmoulins
94800 Villejuif

Registration fees

Late Registration Fees (from October 19)

Course Registration – Single €700
Course Registration – Team** €1100
CIRSE Member – Single €450
CIRSE Member – Team** €700
Nurse/Radiographer Non-Member* €380
Nurse/Radiographer Member* €310

Registration needs to be accompanied by the Confirmation Form, signed by the head of department.

Upon approval, (interventional) radiologists attending the course may bring with them a colleague from the same hospital but a different medical specialty, with whom they work together in a multidiscplinary team which is relevant for the treatment of the patient. These two physicians will then be able to attend the ESIR course under the “Team Fee”. Just choose the “Team Fee” and contact with details regarding your non-IR colleague.


Please note that the following are only suggestions. Accommodation is not included in the registration fee of ESIR courses. CIRSE supports compliance with ethical standards. Therefore, CIRSE emphasises that the participants shall bear any and all costs in this context themselves.

Hotel Mercure Paris Gobelins Place d’Italie 

8 bis Avenue de la Soeur Rosalie
75013 Paris
Phone: +33 1 43 36 62 00
Fax: +33 1 43 36 52 89

Hotel Mercure Paris Place d’Italie Hotel

25 boulevard Auguste Blanqui
75013 Paris
Phone: +33 1 45 80 82 23
Fax: +33 1 45 81 45 84

ibis Paris Place d’Italie 13th

25, avenue Stephen Pichon
75013 Paris
Phone: +33 1 44 24 94 85
Fax: +33 1 44 24 20 70

Hotel Paris Marriott Rive Gauche Hotel

17 Boulevard Saint Jacques
75014 Paris
Phone: +33 1 40 78 79 80
Fax: +33 1 45 88 43 93

citizenM Paris Gare de Lyon

8 Rue van Gogh
75012 Paris
Phone: +33 1 86 65 07 40 

Mercure Paris Notre Dame Saint Germain des Prés

20 Rue Sommerard
75005 Paris
Phone: +33 1 43 54 47 60
Fax: +33 1 43 26 42 34

CME credit allowance 

The ESIR 2018: DEB & cTACE in Primary and Secondary Liver Cancer, Villejuif, France, 13/12/2018-14/12/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.